Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free VLG Stock Alerts

Venture Life Group (VLG) Competitors

Venture Life Group logo
GBX 66.92 +1.93 (+2.96%)
As of 08:00 AM Eastern
Compare

VLG vs. ANCR, BXP, EAH, STX, and DNL

Should you buy Venture Life Group stock or one of its competitors? MarketBeat compares Venture Life Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Venture Life Group include Animalcare Group (ANCR), Beximco Pharmaceuticals (BXP), ECO Animal Health Group (EAH), Shield Therapeutics (STX), and Diurnal Group (DNL). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Venture Life Group compare to Animalcare Group?

Venture Life Group (LON:VLG) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Venture Life Group has a beta of 0.239, suggesting that its share price is 76% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.694, suggesting that its share price is 31% less volatile than the broader market.

Venture Life Group has a net margin of 17.42% compared to Animalcare Group's net margin of 5.70%. Venture Life Group's return on equity of 7.82% beat Animalcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Animalcare Group 5.70%4.46%2.97%

22.9% of Venture Life Group shares are held by institutional investors. Comparatively, 16.1% of Animalcare Group shares are held by institutional investors. 7.1% of Venture Life Group shares are held by company insiders. Comparatively, 30.1% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Venture Life Group had 6 more articles in the media than Animalcare Group. MarketBeat recorded 6 mentions for Venture Life Group and 0 mentions for Animalcare Group. Venture Life Group's average media sentiment score of 0.00 equaled Animalcare Group'saverage media sentiment score.

Company Overall Sentiment
Venture Life Group Neutral
Animalcare Group Neutral

Animalcare Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.32£747.21K£4.3715.31
Animalcare Group£89.11M2.57£36.55M£7.3045.49

Summary

Animalcare Group beats Venture Life Group on 8 of the 12 factors compared between the two stocks.

How does Venture Life Group compare to Beximco Pharmaceuticals?

Beximco Pharmaceuticals (LON:BXP) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Venture Life Group has a net margin of 17.42% compared to Beximco Pharmaceuticals' net margin of 13.13%. Beximco Pharmaceuticals' return on equity of 12.72% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Beximco Pharmaceuticals13.13% 12.72% 6.97%
Venture Life Group 17.42%7.82%1.56%

Beximco Pharmaceuticals has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.239, meaning that its stock price is 76% less volatile than the broader market.

In the previous week, Venture Life Group had 6 more articles in the media than Beximco Pharmaceuticals. MarketBeat recorded 6 mentions for Venture Life Group and 0 mentions for Beximco Pharmaceuticals. Beximco Pharmaceuticals' average media sentiment score of 0.00 equaled Venture Life Group'saverage media sentiment score.

Company Overall Sentiment
Beximco Pharmaceuticals Neutral
Venture Life Group Neutral

1.2% of Beximco Pharmaceuticals shares are owned by institutional investors. Comparatively, 22.9% of Venture Life Group shares are owned by institutional investors. 4.2% of Beximco Pharmaceuticals shares are owned by company insiders. Comparatively, 7.1% of Venture Life Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Beximco Pharmaceuticals has higher revenue and earnings than Venture Life Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beximco Pharmaceuticals£46.34B0.00£970.84B£1.43 thousand0.03
Venture Life Group£35.17M2.32£747.21K£4.3715.31

Summary

Beximco Pharmaceuticals and Venture Life Group tied by winning 6 of the 12 factors compared between the two stocks.

How does Venture Life Group compare to ECO Animal Health Group?

ECO Animal Health Group (LON:EAH) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, Venture Life Group had 6 more articles in the media than ECO Animal Health Group. MarketBeat recorded 6 mentions for Venture Life Group and 0 mentions for ECO Animal Health Group. ECO Animal Health Group's average media sentiment score of 0.00 equaled Venture Life Group'saverage media sentiment score.

Company Overall Sentiment
ECO Animal Health Group Neutral
Venture Life Group Neutral

41.0% of ECO Animal Health Group shares are held by institutional investors. Comparatively, 22.9% of Venture Life Group shares are held by institutional investors. 11.2% of ECO Animal Health Group shares are held by company insiders. Comparatively, 7.1% of Venture Life Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ECO Animal Health Group has a beta of 0.008, meaning that its share price is 99% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.239, meaning that its share price is 76% less volatile than the broader market.

ECO Animal Health Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECO Animal Health Group£85.81M0.73£1.05M£4.3921.29
Venture Life Group£35.17M2.32£747.21K£4.3715.31

ECO Animal Health Group currently has a consensus target price of GBX 160, suggesting a potential upside of 71.16%. Given ECO Animal Health Group's stronger consensus rating and higher possible upside, research analysts plainly believe ECO Animal Health Group is more favorable than Venture Life Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Venture Life Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Venture Life Group has a net margin of 17.42% compared to ECO Animal Health Group's net margin of 3.52%. Venture Life Group's return on equity of 7.82% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ECO Animal Health Group3.52% 3.55% 2.14%
Venture Life Group 17.42%7.82%1.56%

Summary

ECO Animal Health Group beats Venture Life Group on 10 of the 15 factors compared between the two stocks.

How does Venture Life Group compare to Shield Therapeutics?

Venture Life Group (LON:VLG) and Shield Therapeutics (LON:STX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Venture Life Group has a beta of 0.239, indicating that its share price is 76% less volatile than the broader market. Comparatively, Shield Therapeutics has a beta of 1.877, indicating that its share price is 88% more volatile than the broader market.

Venture Life Group has a net margin of 17.42% compared to Shield Therapeutics' net margin of -35.72%. Shield Therapeutics' return on equity of 121.87% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Shield Therapeutics -35.72%121.87%-47.85%

In the previous week, Venture Life Group had 5 more articles in the media than Shield Therapeutics. MarketBeat recorded 6 mentions for Venture Life Group and 1 mentions for Shield Therapeutics. Venture Life Group's average media sentiment score of 0.00 equaled Shield Therapeutics'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venture Life Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Shield Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Venture Life Group has higher earnings, but lower revenue than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.32£747.21K£4.3715.31
Shield Therapeutics£49.70M1.24-£36.28M-£2.00N/A

22.9% of Venture Life Group shares are held by institutional investors. Comparatively, 1.1% of Shield Therapeutics shares are held by institutional investors. 7.1% of Venture Life Group shares are held by insiders. Comparatively, 3.0% of Shield Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Shield Therapeutics has a consensus target price of GBX 15, suggesting a potential upside of 159.07%. Given Shield Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Shield Therapeutics is more favorable than Venture Life Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venture Life Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Shield Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Venture Life Group beats Shield Therapeutics on 9 of the 15 factors compared between the two stocks.

How does Venture Life Group compare to Diurnal Group?

Diurnal Group (LON:DNL) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

In the previous week, Venture Life Group had 6 more articles in the media than Diurnal Group. MarketBeat recorded 6 mentions for Venture Life Group and 0 mentions for Diurnal Group. Diurnal Group's average media sentiment score of 0.00 equaled Venture Life Group'saverage media sentiment score.

Company Overall Sentiment
Diurnal Group Neutral
Venture Life Group Neutral

Venture Life Group has a net margin of 17.42% compared to Diurnal Group's net margin of 0.00%. Venture Life Group's return on equity of 7.82% beat Diurnal Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Diurnal GroupN/A N/A N/A
Venture Life Group 17.42%7.82%1.56%

22.9% of Venture Life Group shares are held by institutional investors. 7.1% of Venture Life Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Venture Life Group has higher revenue and earnings than Diurnal Group. Diurnal Group is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diurnal Group£4.68M0.00N/A-£8.50N/A
Venture Life Group£35.17M2.32£747.21K£4.3715.31

Summary

Venture Life Group beats Diurnal Group on 9 of the 9 factors compared between the two stocks.

Get Venture Life Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VLG vs. The Competition

Export
MetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£81.53M£7.44B£6.47B£2.77B
Dividend Yield0.09%2.95%2.69%6.12%
P/E Ratio15.314.8322.12363.81
Price / Sales2.321,762.85524.8887,542.70
Price / Cash6.4010.1841.3427.85
Price / Book1.1410.919.957.81
Net Income£747.21K£20.70B£3.57B£5.89B
7 Day Performance18.74%-0.82%-2.46%0.09%
1 Year Performance22.69%15.28%26.57%74.59%

Venture Life Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VLG
Venture Life Group
N/AGBX 66.93
+3.0%		N/A+19.7%£81.53M£35.17M15.31165
ANCR
Animalcare Group
N/AGBX 333
flat		N/A+11.2%£229.92M£81.07M92.50220
BXP
Beximco Pharmaceuticals
N/AGBX 42.50
flat		N/AN/A£189.60M£46.34B0.035,500
EAH
ECO Animal Health Group
N/AGBX 95.50
flat		GBX 160
+67.5%		+55.8%£64.07M£85.81M21.75234
STX
Shield Therapeutics
1.2571 of 5 stars		GBX 5.91
flat		GBX 15
+153.8%		+137.5%£63.14M£49.70MN/A40,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:VLG) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners
A gold storm is coming – are you ready?
The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...
Traders Agency | Sponsoredtc pixel
How to claim a stake in SpaceX before the June 12 IPO
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
The chokepoint supplier behind SpaceX's $1.75 trillion empire
When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...
Behind the Markets | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
AI breakthrough hidden inside SpaceX exposed on June 11
On June 11, SpaceX is hosting a major investor event - and growth investor Louis Navellier believes Elon Musk ...
InvestorPlace | Sponsoredtc pixel
Important SpaceX PREDICTION from Trading Legend Jon Najarian
Trading legend Jon Najarian says the real story behind the projected June 12 SpaceX IPO isn't the IPO itself -...
Banyan Hill Publishing | Sponsoredtc pixel